Cargando…

SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors

A set of 25 novel, silicon-based carbamate derivatives as potential acetyl- and butyrylcholinesterase (AChE/BChE) inhibitors was synthesized and characterized by their in vitro inhibition profiles and the selectivity indexes (SIs). The prepared compounds were also tested for their inhibition potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bak, Andrzej, Pizova, Hana, Kozik, Violetta, Vorcakova, Katarina, Kos, Jiri, Treml, Jakub, Odehnalova, Klara, Oravec, Michal, Imramovsky, Ales, Bobal, Pavel, Smolinski, Adam, Trávníček, Zdeněk, Jampilek, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862691/
https://www.ncbi.nlm.nih.gov/pubmed/31671776
http://dx.doi.org/10.3390/ijms20215385
_version_ 1783471612953100288
author Bak, Andrzej
Pizova, Hana
Kozik, Violetta
Vorcakova, Katarina
Kos, Jiri
Treml, Jakub
Odehnalova, Klara
Oravec, Michal
Imramovsky, Ales
Bobal, Pavel
Smolinski, Adam
Trávníček, Zdeněk
Jampilek, Josef
author_facet Bak, Andrzej
Pizova, Hana
Kozik, Violetta
Vorcakova, Katarina
Kos, Jiri
Treml, Jakub
Odehnalova, Klara
Oravec, Michal
Imramovsky, Ales
Bobal, Pavel
Smolinski, Adam
Trávníček, Zdeněk
Jampilek, Josef
author_sort Bak, Andrzej
collection PubMed
description A set of 25 novel, silicon-based carbamate derivatives as potential acetyl- and butyrylcholinesterase (AChE/BChE) inhibitors was synthesized and characterized by their in vitro inhibition profiles and the selectivity indexes (SIs). The prepared compounds were also tested for their inhibition potential on photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. In fact, some of the newly prepared molecules revealed comparable or even better inhibitory activities compared to the marketed drugs (rivastigmine or galanthamine) and commercially applied pesticide Diuron(®), respectively. Generally, most compounds exhibited better inhibition potency towards AChE; however, a wider activity span was observed for BChE. Notably, benzyl N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(2-hydroxyphenyl)carbamoyl]ethyl]-carbamate (2) and benzyl N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(3-hydroxyphenyl)carbamoyl]ethyl]-carbamate (3) were characterized by fairly high selective indexes. Specifically, compound 2 was prescribed with the lowest IC(50) value that corresponds quite well with galanthamine inhibition activity, while the inhibitory profiles of molecules 3 and benzyl-N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(4-hydroxyphenyl)carbamoyl]ethyl]carbamate (4) are in line with rivastigmine activity. Moreover, a structure–activity relationship (SAR)-driven similarity evaluation of the physicochemical properties for the carbamates examined appeared to have foreseen the activity cliffs using a similarity–activity landscape index for BChE inhibitory response values. The ‘indirect’ ligand-based and ‘direct’ protein-mediated in silico approaches were applied to specify electronic/steric/lipophilic factors that are potentially valid for quantitative (Q)SAR modeling of the carbamate analogues. The stochastic model validation was used to generate an ‘average’ 3D-QSAR pharmacophore pattern. Finally, the target-oriented molecular docking was employed to (re)arrange the spatial distribution of the ligand property space for BChE and photosystem II (PSII).
format Online
Article
Text
id pubmed-6862691
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68626912019-12-05 SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors Bak, Andrzej Pizova, Hana Kozik, Violetta Vorcakova, Katarina Kos, Jiri Treml, Jakub Odehnalova, Klara Oravec, Michal Imramovsky, Ales Bobal, Pavel Smolinski, Adam Trávníček, Zdeněk Jampilek, Josef Int J Mol Sci Article A set of 25 novel, silicon-based carbamate derivatives as potential acetyl- and butyrylcholinesterase (AChE/BChE) inhibitors was synthesized and characterized by their in vitro inhibition profiles and the selectivity indexes (SIs). The prepared compounds were also tested for their inhibition potential on photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. In fact, some of the newly prepared molecules revealed comparable or even better inhibitory activities compared to the marketed drugs (rivastigmine or galanthamine) and commercially applied pesticide Diuron(®), respectively. Generally, most compounds exhibited better inhibition potency towards AChE; however, a wider activity span was observed for BChE. Notably, benzyl N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(2-hydroxyphenyl)carbamoyl]ethyl]-carbamate (2) and benzyl N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(3-hydroxyphenyl)carbamoyl]ethyl]-carbamate (3) were characterized by fairly high selective indexes. Specifically, compound 2 was prescribed with the lowest IC(50) value that corresponds quite well with galanthamine inhibition activity, while the inhibitory profiles of molecules 3 and benzyl-N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(4-hydroxyphenyl)carbamoyl]ethyl]carbamate (4) are in line with rivastigmine activity. Moreover, a structure–activity relationship (SAR)-driven similarity evaluation of the physicochemical properties for the carbamates examined appeared to have foreseen the activity cliffs using a similarity–activity landscape index for BChE inhibitory response values. The ‘indirect’ ligand-based and ‘direct’ protein-mediated in silico approaches were applied to specify electronic/steric/lipophilic factors that are potentially valid for quantitative (Q)SAR modeling of the carbamate analogues. The stochastic model validation was used to generate an ‘average’ 3D-QSAR pharmacophore pattern. Finally, the target-oriented molecular docking was employed to (re)arrange the spatial distribution of the ligand property space for BChE and photosystem II (PSII). MDPI 2019-10-29 /pmc/articles/PMC6862691/ /pubmed/31671776 http://dx.doi.org/10.3390/ijms20215385 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bak, Andrzej
Pizova, Hana
Kozik, Violetta
Vorcakova, Katarina
Kos, Jiri
Treml, Jakub
Odehnalova, Klara
Oravec, Michal
Imramovsky, Ales
Bobal, Pavel
Smolinski, Adam
Trávníček, Zdeněk
Jampilek, Josef
SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors
title SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors
title_full SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors
title_fullStr SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors
title_full_unstemmed SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors
title_short SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors
title_sort sar-mediated similarity assessment of the property profile for new, silicon-based ache/bche inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862691/
https://www.ncbi.nlm.nih.gov/pubmed/31671776
http://dx.doi.org/10.3390/ijms20215385
work_keys_str_mv AT bakandrzej sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT pizovahana sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT kozikvioletta sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT vorcakovakatarina sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT kosjiri sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT tremljakub sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT odehnalovaklara sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT oravecmichal sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT imramovskyales sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT bobalpavel sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT smolinskiadam sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT travnicekzdenek sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors
AT jampilekjosef sarmediatedsimilarityassessmentofthepropertyprofilefornewsiliconbasedachebcheinhibitors